SCHEMBL25646015

SCHEMBL25646015

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccccc34)nc(-c3ccc4c(c3)sc3cccc(-c5ccccc5)c34)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.35
AHR P35869 1/20 0.34
LIMK1 P53667 1/20 0.34
ALDH1A1 P00352 4/20 0.33
MAPT P10636 4/20 0.33
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 2/20 0.33
F9 P00740 1/20 0.33
ALOX5 P09917 1/20 0.33
POLB P06746 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
SLC9A1 P19634 1/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33
NFKB2 Q00653 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25645850 0.99 HCRTR1 (0.34) HCRTR1AHRLIMK1ALDH1A1MAPT
SCHEMBL25645754 0.98 HCRTR1 (0.36) HCRTR1AHRLIMK1ALDH1A1MAPT
SCHEMBL25851955 0.98 HCRTR1 (0.36) HCRTR1AHRLIMK1ALDH1A1MAPT
SCHEMBL25851956 0.97 HCRTR1 (0.35) HCRTR1AHRLIMK1ALDH1A1MAPT
SCHEMBL25646009 0.97 F9 (0.36) HCRTR1AHRLIMK1ALDH1A1MAPT
SCHEMBL22760673 0.96 HCRTR1 (0.36) HCRTR1AHRLIMK1ALDH1A1MAPT
SCHEMBL25645656 0.95 F9 (0.36) HCRTR1AHRLIMK1ALDH1A1MAPT
SCHEMBL22329314 0.95 AHR (0.34) HCRTR1AHRALDH1A1MAPTKDM4E
SCHEMBL25645611 0.95 F9 (0.36) HCRTR1AHRLIMK1ALDH1A1MAPT
SCHEMBL21756047 0.95 ALOX5 (0.34) HCRTR1AHRLIMK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, CYP1A1, CYP1B1 HCRTR1 337/4885AHR 35/4885LIMK1 199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.